William M. McClellan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
William M. McClellan has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Diane L. Frankenfield
3 shared publicationsJay B. Wish
2 shared publicationsPamela R. Frederick
2 shared publicationsRodney Presley
Georgia Medical Care Foundation, 1455 Lincoln Parkway, Suite 500, Atlanta, GA 30346, USA
2 shared publicationsSteven D. Helgerson
2 shared publicationsAna Alfaro-Correa
1 shared publication
Latest Publications
- Open Access
- 6 March 2006
- Published by Springer Nature in BMC Nephrology
- Vol. 7 (1) , 3
Anemia and chronic kidney disease are associated with poor outcomes in heart failure patients
Chronic kidney disease (CKD) has been linked to higher heart failure (HF) risk. Anemia is a common consequence of CKD, and recent evidence suggests that anemia is a risk factor for HF. The purpose of this study was to examine among patients with HF, the association between CKD, anemia and inhospital mortality and early readmission. We performed a retrospective cohort study in two Swiss university hospitals. Subjects were selected based the presence of ICD-10 HF codes in 1999. We recorded demographic characteristics and risk factors for HF. CKD was defined as a serum creatinine ≥ 124 956;mol/L for women and ≥ 133 μmol/L for men. The main outcome measures were inhospital mortality and thirty-day readmissions. Among 955 eligible patients hospitalized with heart failure, 23.0% had CKD. Twenty percent and 6.1% of individuals with and without CKD, respectively, died at the hospital (p < 0.0001). Overall, after adjustment for other patient factors, creatinine and hemoglobin were associated with an increased risk of death at the hospital, and hemoglobin was related to early readmission. Both CKD and anemia are frequent among older patients with heart failure and are predictors of adverse outcomes, independent of other known risk factors for heart failure.
- 6 March 2006
- Published by Springer Nature in BMC Nephrology
- Vol. 7 (1) , 3
Open AccessAnemia and chronic kidney disease are associated with poor outcomes in heart failure patients
Chronic kidney disease (CKD) has been linked to higher heart failure (HF) risk. Anemia is a common consequence of CKD, and recent evidence suggests that anemia is a risk factor for HF. The purpose of this study was to examine among patients with HF, the association between CKD, anemia and inhospital mortality and early readmission. We performed a retrospective cohort study in two Swiss university hospitals. Subjects were selected based the presence of ICD-10 HF codes in 1999. We recorded demographic characteristics and risk factors for HF. CKD was defined as a serum creatinine ≥ 124 956;mol/L for women and ≥ 133 μmol/L for men. The main outcome measures were inhospital mortality and thirty-day readmissions. Among 955 eligible patients hospitalized with heart failure, 23.0% had CKD. Twenty percent and 6.1% of individuals with and without CKD, respectively, died at the hospital (p < 0.0001). Overall, after adjustment for other patient factors, creatinine and hemoglobin were associated with an increased risk of death at the hospital, and hemoglobin was related to early readmission. Both CKD and anemia are frequent among older patients with heart failure and are predictors of adverse outcomes, independent of other known risk factors for heart failure.
- 27 October 2005
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 35 (s3) , 58-65
The epidemiology and control of anaemia among pre‐ESRD patients with chronic kidney disease
Anaemia is a common condition among pre‐end‐stage renal disease (pre‐ESRD) patients with chronic kidney disease (CKD). Indeed, data from clinical studies indicate that anaemia may be present in as many as two‐thirds of such patients. Use of recombinant human erythropoietin (EPO) provides an effective means of correcting anaemia in CKD patients and helps to reduce the risk of renal disease progression and related problems. Unfortunately, EPO therapy is underutilized in these persons. Consequently, anaemia remains a major problem in the pre‐ESRD CKD population. Evidence suggests that anaemia in the presence of CKD can lead to an increased risk of a number of adverse outcomes, including mortality, progression of kidney disease, coronary heart disease, stroke, hospitalization, and decreases in quality of life. Anaemia's association with these adverse outcomes suggests that effective treatment of anaemia in pre‐ESRD CKD patients is of great importance and that substantial efforts should be made to ensure that these patients receive appropriate therapy to correct anaemia.
- 27 October 2005
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 35 (s3) , 58-65
The epidemiology and control of anaemia among pre‐ESRD patients with chronic kidney disease
Anaemia is a common condition among pre‐end‐stage renal disease (pre‐ESRD) patients with chronic kidney disease (CKD). Indeed, data from clinical studies indicate that anaemia may be present in as many as two‐thirds of such patients. Use of recombinant human erythropoietin (EPO) provides an effective means of correcting anaemia in CKD patients and helps to reduce the risk of renal disease progression and related problems. Unfortunately, EPO therapy is underutilized in these persons. Consequently, anaemia remains a major problem in the pre‐ESRD CKD population. Evidence suggests that anaemia in the presence of CKD can lead to an increased risk of a number of adverse outcomes, including mortality, progression of kidney disease, coronary heart disease, stroke, hospitalization, and decreases in quality of life. Anaemia's association with these adverse outcomes suggests that effective treatment of anaemia in pre‐ESRD CKD patients is of great importance and that substantial efforts should be made to ensure that these patients receive appropriate therapy to correct anaemia.
- 1 May 2005
- Published by Elsevier in Medical Clinics of North America
- Vol. 89 (3) , 419-445
Epidemiology and Risk Factors for Chronic Kidney Disease
- 1 May 2005
- Published by Elsevier in Medical Clinics of North America
- Vol. 89 (3) , 419-445
Epidemiology and Risk Factors for Chronic Kidney Disease
- 1 December 2003
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 56 (12) , 1210-1217
Improved diabetes care by primary care physicians: results of a group-randomized evaluation of the Medicare Health Care Quality Improvement Program (HCQIP)
- 1 December 2003
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 56 (12) , 1210-1217
Improved diabetes care by primary care physicians: results of a group-randomized evaluation of the Medicare Health Care Quality Improvement Program (HCQIP)
- 1 January 2003
- Vol. 24 (4) , 89-100
Improving the Care of ESRD Patients: A Success Story
Medicare's health care quality improvement program (HCQIP) is a national effort to improve beneficiaries' quality of care. The end stage renal disease (ESRD) HCQIP was implemented in 1994 in response to criticism about the poor quality of care received by ESRD patients. Quality improvement efforts initiated by the ESRD Networks and dialysis providers in response to the HCQIP have demonstrated substantial improvement in care for dialysis patients. This article describes the evolution of the ESRD HCQIP and its successful application in the ESRD program.
- 1 January 2003
- Vol. 24 (4) , 89-100
Improving the Care of ESRD Patients: A Success Story
Medicare's health care quality improvement program (HCQIP) is a national effort to improve beneficiaries' quality of care. The end stage renal disease (ESRD) HCQIP was implemented in 1994 in response to criticism about the poor quality of care received by ESRD patients. Quality improvement efforts initiated by the ESRD Networks and dialysis providers in response to the HCQIP have demonstrated substantial improvement in care for dialysis patients. This article describes the evolution of the ESRD HCQIP and its successful application in the ESRD program.
- Top Cited Papers
- 1 August 2002
- Published by Elsevier in Kidney International
- Vol. 62 (2) , 620-626
Vascular access and increased risk of death among hemodialysis patients
- 1 August 2002
- Published by Elsevier in Kidney International
- Vol. 62 (2) , 620-626
Top Cited PapersVascular access and increased risk of death among hemodialysis patients
- 1 July 2002
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 13 (7) , 1928-1936
Anemia and Renal Insufficiency Are Independent Risk Factors for Death among Patients with Congestive Heart Failure Admitted to Community Hospitals
The purpose of this retrospective cohort study was to examine the associations among chronic kidney disease, anemia, and risk of death among patients with heart failure. Retrospective cohort study. Patients with a principal diagnosis of heart failure (ICD9 codes 402.01, 402.11, 402.91, 404.01, 404.11, 404.91, and 428.xx) were included. Chronic kidney disease (CKD) was defined as a serum creatinine >1.4 mg/dl for women and >1.5 mg/dl for men. There were 665 eligible patients in the sample with a mean (SD) age of 75.7 (10.9) yr; 60% were women, 71% were white, and 38% had CKD. On admission, a hematocrit ≥40% was found for 30.3% of the patients; 22.9% had a hematocrit between 36% and 40%, 33.2% between 30% and 35%, and 13.6% had a hematocrit of 2 for trend was 7.37; P = 0.007). Both hematocrit and serum creatinine were independently associated with increased risk of death during follow-up after controlling for other patient risk factors. In conclusion, CKD and anemia are frequent among older patients with heart failure and are independent predictors of subsequent risk of death.
- 1 July 2002
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 13 (7) , 1928-1936
Anemia and Renal Insufficiency Are Independent Risk Factors for Death among Patients with Congestive Heart Failure Admitted to Community Hospitals
The purpose of this retrospective cohort study was to examine the associations among chronic kidney disease, anemia, and risk of death among patients with heart failure. Retrospective cohort study. Patients with a principal diagnosis of heart failure (ICD9 codes 402.01, 402.11, 402.91, 404.01, 404.11, 404.91, and 428.xx) were included. Chronic kidney disease (CKD) was defined as a serum creatinine >1.4 mg/dl for women and >1.5 mg/dl for men. There were 665 eligible patients in the sample with a mean (SD) age of 75.7 (10.9) yr; 60% were women, 71% were white, and 38% had CKD. On admission, a hematocrit ≥40% was found for 30.3% of the patients; 22.9% had a hematocrit between 36% and 40%, 33.2% between 30% and 35%, and 13.6% had a hematocrit of 2 for trend was 7.37; P = 0.007). Both hematocrit and serum creatinine were independently associated with increased risk of death during follow-up after controlling for other patient risk factors. In conclusion, CKD and anemia are frequent among older patients with heart failure and are independent predictors of subsequent risk of death.
- 1 April 2001
- Published by Elsevier in Advances in Renal Replacement Therapy
- Vol. 8 (2) , 95-103
Continuous Quality Improvement in Dialysis Units: Basic Tools
- 1 April 2001
- Published by Elsevier in Advances in Renal Replacement Therapy
- Vol. 8 (2) , 95-103
Continuous Quality Improvement in Dialysis Units: Basic Tools
- 1 December 1999
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 34 (6) , 1075-1082
Can dialysis therapy be improved? A report from the ESRD Core Indicators Project
- 1 December 1999
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 34 (6) , 1075-1082
Can dialysis therapy be improved? A report from the ESRD Core Indicators Project